Global consumption of the Prefilled Formalin Vials Market stood at around US$ 388.3 Million in 2021 and is slated to increase at a CAGR of 4.1% to reach a valuation of US$ 515.8 Million by 2028.
| Data Points | Market Insights |
|---|---|
| Estimated Global Market Value (2022) | USD 405.2 Million |
| Forecasted Global Market Value (2028) | USD 515.8 Million |
| Market Growth Rate 2022 to 2028 | 4.1% |
| Top 5 Countries % Share | 47.2% |
| Key Players | Histo- Line Laboratories Srl; Cardinal Health, Inc.; Leica Microsystems GmbH; Diapath S.p.A; Genta Environmental Ltd; Carl Roth GmbH; Magnacol Ltd.; Serosep Limited; Ultident Scientific and Solmedia Limited. |
Formaldehyde also known as methanol is a naturally occurring organic compound with the formula CH2O (H-CHO). Prefilled formalin vials are in high demand due to its widespread application in the manufacturing of methanol-based resins. Urea-formaldehyde, urea-melamine-formaldehyde, and melamine-formaldehyde resins are used in a variety of industrial applications.
Prefilled formalin vials market size is expected to register substantial growth owing to the broad application scope of the substance in biopsies conducted in operating rooms, pathology labs, and other medical facilities. Prefilled formalin vials refer to sterilized containers that provide easier visualization of samples in healthcare sectors. Wide-mouth, clarified polypropylene containers are commonly used for these vials, and allow a more autoclavable, crack-resistant, and flexible way to visualize specimens.
Increased focus on production of prefilled formalin vials to be used in hospital pathology labs is significantly expected to determine the market landscape in global market over the forecast period. Prefilled formalin vials are widely used in histopathology to preserve biopsy tissue samples, thereby, driving the demand of prefilled formalin vials providers in the industry.
Government support helps in the growth of the regional biotechnology and healthcare industry by offering tax exemptions for R&D, increased budgets and funding and attracting foreign direct investments. With the growing number of pharmaceutical industries and advancing veterinary industry, prefilled formalin vials experience increased demand from these end use facilities. This is expected to have vast opportunity to dwell their business of prefilled formalin vials from end use settings such as hospitals, CROs, forensic laboratories and academic institutes.
Prefilled formalin vials and tubes are safe and have advantage of preventing direct exposure of formalin with the pathologist, thus they have high adoption over the past five years and is projected to be same over the forecast period.
Acquisitions, capacity expansion, product launches and adoption of new technology based products are the key strategies adopted by manufacturers to increase the sale in different geographies.
Additionally, manufacturers are focusing on forward integration with partnerships with wholesalers, distributors and other channel partners to gain ownership over value chain in prefilled formalin vials market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 4.14% |
| H1, 2022 Projected | 4.10% |
| H1, 2022 Outlook | 4.00% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 14 ↓ |
In the present scenario, prefilled formalin vials can be used for various applications in forensic labs, diagnostics and veterinary labs. Growing import and export of the formalin vials in European countries have created a huge market demand for manufacturers in the region.
The prefilled formalin vials market is subject to influence by rise in adoption of prefilled formalin vials because of their safe status and least exposure to the pathologist while in use. As per the comparative analysis by Future Market Insights for market growth rate in 2021 and 2022, a decrease in 14 Basis Point Share (BPS) is expected in H1-2022 (O), as compared with H1-2021.
This owes to the high risk of cancer upon direct exposure of formalin. Whereas, in comparison to H1-2022 Projected value, the market during H1-2022 outlook period will show a dip of 10 BPS.
Other factors which might be involved in downfall of BPS include regulatory implications on formaldehyde emissions. To address this issue, key players have been focusing on expanding their product portfolio for the consumer’s safety and rise in R&D investments.
Additionally, there has been rise in adoption of formalin as a disinfectant attributing to its broad spectrum of disinfection. For instance, In India, hospitals and surgical clinics make use of formalin as a primary disinfectant to avoid contamination and maintain a sterile environment. These factors present some positive market growth opportunities for sale of prefilled formalin vials.
Sales of prefilled formalin vials market grew at a CAGR of 3.6% between 2013 and 2021.
In 2021, the global market of prefilled formalin vials accounts for approx. 3.3% of the overall pharmaceutical vials market that accounts for around US$ 11.6 Bn.
Increased usage of formalin as a preservative is creating huge market opportunities. Formaldehyde is used as a preservative product in medical laboratories, mortuaries, cosmetics, medicines and antiseptics. When dissolved in water it is called formalin, which is used as a preservative and industrial disinfectant.
The aqueous solution is an effective tuberculocide, virucide, bactericide, fungicide, and sporicide. Formaldehyde in form of formalin can be used as a sterilant, preservative and disinfectant in both its liquid and gaseous states and therefore, can drive the demand for prefilled formalin vials market.
In clinical diagnostic procedures, formalin fixation is the basic procedural requirement of standardized tissue preservation. Other fixatives would lead to increased rate of histological misdiagnoses if followed by wrong treatment decisions. Thus formalin is the best preferred fixative agent used in histopathology over other alternatives, thereby driving the prefilled formalin vials market growth over the years.
The global prefilled formalin vials market is expected to grow at a CAGR of 4.1% through the forecast period 2022-2028.
Principal Consultant
Despite the fact that the COVID-19 crisis accelerated global research and development efforts aimed at preventing the spread of the virus, it has brought a halt to a wide range of organizations and industries, including the healthcare industry. The prefilled formalin vials market was one of them.
Over the last year, substantial progress has been made in vaccine development, manufacture, and distribution, with several pharmaceutical companies focusing their efforts on preventing the spread of the COVID-19 disease. Given the use of inactivating substances like formaldehyde for the destruction of bacteria, viruses, or toxins in the vaccine, this has resulted in a gain in market share of prefilled formalin vials.
High risk of occupational exposure to formalin might hamper the growth of market over the forecast period.
World Health Organization (WHO) suggested that, “because formaldehyde is ubiquitous, occupational exposure occurs in all workplaces”. European Union (EU), estimated in 2017 that more than nine lakh workers were evaluated to be exposed to formaldehyde above the background level. Out of these, 175,380 exposed workers to formaldehyde were registered in Italy.
Formalin is usually recognized as a toxic chemical which cause sensory irritation of eyes and upper respiratory tract. A short-term occupational exposure level (OEL) of 0.4 ppm that ranges for about 15 minutes needs to be maintained for workers’ protection from cancer causing effects. However, a number of evidences are registered where formalin or formaldehyde exposure shows association with cancer in humans, mainly the nasopharyngeal site of the upper respiratory tract, thereby hampering the demand of formaldehyde over years.
Moreover, owing to the high risks of developing cancer on exposure to formalin in workplace. It is best to avoid excessive amount or prolonged exposure to formaldehyde by professionals, thereby hampering the formalin demand in the industries. This is expected to have a negative impact of the global formalin market in the forthcoming years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The U.S. is estimated to account for around 86.3% of the North America prefilled formalin vials market in 2022 owing to the constant flux of new product lines, rising clinical research by CROs, and rising cancer awareness programs which give information about the cancer. Initiatives program by U.S government to enhance availability of cancer diagnosis is projected to fuel growth of prefilled formalin vials market.
On January 20, 2016, the U.S. government announced establishment of Cancer Moonshot to accelerate cancer research in the U.S. The initiative is aimed to make more therapies available to the patients to improve and detect cancer at early stage, thereby increasing demand for prefilled formalin vials.
Germany is estimated to account for 32.4% market revenue share in Europe in 2022. Industrial advancement, technological advancement and research and development spending are the major factors boosting the demand for prefilled formalin vials market in Germany.
Over the past few years, major industries especially pharmaceutical and biotechnology have been experiencing a shift from investment in R&D and technology, from North America to Europe and Asia Pacific. The developed European countries particularly Germany have ample skilled labor and qualified manpower and upgraded technology, thereby, increasing the scope for attracting formalin manufacturers and distributors. This is expected to drive the demand for this market in this Country.
U.K is expected to have huge growth due to technological advances and high healthcare expenditure with an estimated growth CAGR of 3.9% by 2028.
U.K market offers vast opportunities for prefilled formalin vials (including IV tubing sets) exporters within the region in order to enhance revenue generation in European prefilled formalin vials market. In U.K, a number of manufacturing activities including set up of new manufacturing facilities within the country and growing import and export of prefilled formalin vials is expected to give good contribution to market growth.
Recently demand for prefilled formalin vials market in China is rising and contribute 36.8% market revenue share in Asia Pacific region in 2022.
China have large population and high incidence of cancer cases. However, number of facilities and experienced practitioners available in these country are relatively low in order to provide effective treatment. Growing incidence of cancer in China is expected to offer lucrative growth opportunities for prefilled formalin vials manufacturers, as formalin finds major application as tissue fixative in histopathology of cancer cells.
Hospitals, cancer centers and clinics that provide cancer diagnosis is gradually increasing in China, which translated into an opportunity for prefilled formalin vials providers to introduce less complicated, cost-effective and easily available products in the region.
Additionally, increasing awareness and disease prevalence along with strong foothold of leading industry players generated abundant growth potential in this region.
90 - 500 mL accounts for the highest global revenue share of nearly 23.8% in 2021 due to safety and convenience associated with the usage of prefilled formalin vials along with its rising adoption in the field of forensic and diagnostics, thereby, driving the segment growth.
Moreover, ease of formalin usage as tissue fixative in cancer diagnostic in histopathology, low price of prefilled formalin vials and containers with 10% neutral buffered formalin are also the major factors that will drive the demand for 90 - 500 mL by Product.
By end user, contract research organizations (CROs) lead the global market with market share of 28.9% in 2021 owing to increased use of formalin carried out in CROs. CROs researches are established for biopharmaceutical development, biologic assay development, preclinical research, clinical research, clinical trials and almost all type of research where formalin is used in huge quantity.
Additionally, prefilled formalin vials are easily handled in CROs and for the preservation of biological specimens and tissues, formalin is necessary. Thus, increased demand for formalin vials by contract research organizations will foster segmental growth.
The prefilled formalin vials market have major competitors such as Diapath S.p.A, Histo- Line Laboratories Srl, Cardinal Health, Inc., Leica Microsystems Sales GmbH (Leica Biosystems Nussloch GmbH), Genta Environmental Ltd., Carl Roth GmbH + Co. KG, Magnacol Ltd., Serosep Limited, Ultident Scientific and Solmedia Limited.
To attract more customers and expand product portfolio, the major players are focusing on increasing their market share in the developed economies through partnership with regional players as well as investment groups. On the other hand, regional market players are focusing on making long-term relationships with direct end-users to sustain continuous revenue flow. For instance.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2028 |
| Historical Data Available for | 2013 to 2021 |
| Market Analysis | USD Million for Value and Volume in Unit |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Spain, Italy, Spain, Russia, Poland, China, Japan, South Korea, India, Australia, New Zealand, GCC Countries, South Africa |
| Key Segments Covered | Product, End User and Region |
| Key Companies Profiled | Diapath; Histo- Line Laboratories; Cardinal Health; Leica Biosystems Nussloch; Genta Environmental; Carl Roth GmbH; Magnacol Ltd.; Serosep Limited; Ultident Scientific; Solmedia Limited |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global prefilled formalin vials market is worth US$ 388.3 Mn in 2021 and is set to expand with CAGR of 4.1% over forecast period.
The market is expected to reach US$ 515.8 Mn by the end of 2028.
The sales of prefilled formalin vials market have grown at a CAGR of nearly 3.6% between 2013 and 2021.
90-500 mL vials have huge growth opportunities in prefilled formalin vials market and is expected to grow at a CAGR of nearly 3.8% between 2022 and 2028.
U.S., China and Germany are the top 3 countries that are driving the demand.
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Company Description and Prefilled Formalin Vials Market Research Coverage
3. Prefilled Formalin Vials Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. List of Growth Hacking Manufacturers
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.2.4. Opportunity
4.3. Regulatory Scenario
5. Regulatory Scenario Global Economic Outlook
5.1. Prefilled Formalin Vials Market Outlook
6. Key Inclusions
6.1. Target Market Scenario
6.2. Key Distributors List
6.3. Pricing Analysis By Country
6.4. Formaldehyde Consumption, By Country
6.5. Region Wise Formalin Demand Scenario
6.6. Global Key Competition Mapping
7. North America Prefilled Formalin Vials Market Analysis 2013–2021 and Forecast 2022–2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2022-2028
7.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product Type, 2013-2021
7.4.1. <10 mL
7.4.2. 10 – 20 mL
7.4.3. 20 – 40 mL
7.4.4. 40 – 60 mL
7.4.5. 60 – 90 mL
7.4.6. 90 – 500 mL
7.4.7. 500 mL – 1 lit.
7.5. Market Size (US$ Mn) Forecast By Product Type, 2022-2028
7.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
7.6.1. Hospitals
7.6.2. Clinics
7.6.3. Emergency Medical Services
7.6.4. Diagnostic Laboratories
7.6.5. Academic Institutes
7.6.6. Forensic Laboratories
7.6.7. Contract Research Organizations
7.6.8. Veterinary Clinics
7.6.9. Veterinary Laboratories
7.6.10. Veterinary Hospitals
7.7. Market Size (US$ Mn) Forecast By End User, 2022-2028
7.8. Drivers and Restraints: Impact Analysis
7.9. Market Attractiveness Analysis
7.9.1. By Country
7.9.2. By Product Type
7.9.3. By End User
7.10. Key Mergers & Acquisitions
8. Latin America Prefilled Formalin Vials Market Analysis 2013–2021 and Forecast 2022–2028
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2022-2028
8.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product Type, 2013-2021
8.4.1. <10 mL
8.4.2. 10 – 20 mL
8.4.3. 20 – 40 mL
8.4.4. 40 – 60 mL
8.4.5. 60 – 90 mL
8.4.6. 90 – 500 mL
8.4.7. 500 mL – 1 lit.
8.5. Market Size (US$ Mn) Forecast By Product Type, 2022-2028
8.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
8.6.1. Hospitals
8.6.2. Clinics
8.6.3. Emergency Medical Services
8.6.4. Diagnostic Laboratories
8.6.5. Academic Institutes
8.6.6. Forensic Laboratories
8.6.7. Contract Research Organizations
8.6.8. Veterinary Clinics
8.6.9. Veterinary Laboratories
8.6.10. Veterinary Hospitals
8.7. Market Size (US$ Mn) Forecast By End User, 2022-2028
8.8. Drivers and Restraints: Impact Analysis
8.9. Market Attractiveness Analysis
8.9.1. By Country
8.9.2. By Product Type
8.9.3. By End User
8.10. Key Mergers & Acquisitions
9. Western Europe Prefilled Formalin Vials Market Analysis 2013–2021 and Forecast 2022–2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
9.2.1. Germany
9.2.2. U.K
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Western Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2022-2028
9.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product Type, 2013-2021
9.4.1. <10 mL
9.4.2. 10 – 20 mL
9.4.3. 20 – 40 mL
9.4.4. 40 – 60 mL
9.4.5. 60 – 90 mL
9.4.6. 90 – 500 mL
9.4.7. 500 mL – 1 lit.
9.5. Market Size (US$ Mn) Forecast By Product Type, 2022-2028
9.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
9.6.1. Hospitals
9.6.2. Clinics
9.6.3. Emergency Medical Services
9.6.4. Diagnostic Laboratories
9.6.5. Academic Institutes
9.6.6. Forensic Laboratories
9.6.7. Contract Research Organizations
9.6.8. Veterinary Clinics
9.6.9. Veterinary Laboratories
9.6.10. Veterinary Hospitals
9.7. Market Size (US$ Mn) Forecast By End User, 2022-2028
9.8. Drivers and Restraints: Impact Analysis
9.9. Market Attractiveness Analysis
9.9.1. By Country
9.9.2. By Product Type
9.9.3. By End User
9.10. Key Mergers & Acquisitions
10. Eastern Europe Prefilled Formalin Vials Market Analysis 2013–2021 and Forecast 2022–2028
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
10.2.1. Russia
10.2.2. Poland
10.2.3. Rest of Eastern Europe
10.3. Market Size (US$ Mn) Forecast By Country, 2022-2028
10.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product Type, 2013-2021
10.4.1. <10 mL
10.4.2. 10 – 20 mL
10.4.3. 20 – 40 mL
10.4.4. 40 – 60 mL
10.4.5. 60 – 90 mL
10.4.6. 90 – 500 mL
10.4.7. 500 mL – 1 lit.
10.5. Market Size (US$ Mn) Forecast By Product Type, 2022-2028
10.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
10.6.1. Hospitals
10.6.2. Clinics
10.6.3. Emergency Medical Services
10.6.4. Diagnostic Laboratories
10.6.5. Academic Institutes
10.6.6. Forensic Laboratories
10.6.7. Contract Research Organizations
10.6.8. Veterinary Clinics
10.6.9. Veterinary Laboratories
10.6.10. Veterinary Hospitals
10.7. Market Size (US$ Mn) Forecast By End User, 2022-2028
10.8. Drivers and Restraints: Impact Analysis
10.9. Market Attractiveness Analysis
10.9.1. By Country
10.9.2. By Product Type
10.9.3. By End User
10.10. Key Mergers & Acquisitions
11. Asia Pacific Excluding Japan Prefilled Formalin Vials Market Analysis 2013–2021 and Forecast 2022–2028
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
11.2.1. China
11.2.2. India
11.2.3. Australia & New Zealand
11.2.4. ASEAN
11.2.5. Rest of APEJ
11.3. Market Size (US$ Mn) Forecast By Country, 2022-2028
11.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product Type, 2013-2021
11.4.1. <10 mL
11.4.2. 10 – 20 mL
11.4.3. 20 – 40 mL
11.4.4. 40 – 60 mL
11.4.5. 60 – 90 mL
11.4.6. 90 – 500 mL
11.4.7. 500 mL – 1 lit.
11.5. Market Size (US$ Mn) Forecast By Product Type, 2022-2028
11.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
11.6.1. Hospitals
11.6.2. Clinics
11.6.3. Emergency Medical Services
11.6.4. Diagnostic Laboratories
11.6.5. Academic Institutes
11.6.6. Forensic Laboratories
11.6.7. Contract Research Organizations
11.6.8. Veterinary Clinics
11.6.9. Veterinary Laboratories
11.6.10. Veterinary Hospitals
11.7. Market Size (US$ Mn) Forecast By End User, 2022-2028
11.8. Drivers and Restraints: Impact Analysis
11.9. Market Attractiveness Analysis
11.9.1. By Country
11.9.2. By Product Type
11.9.3. By End User
11.10. Key Mergers & Acquisitions
12. Japan Prefilled Formalin Vials Market Analysis 2013–2021 and Forecast 2022–2028
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product Type, 2013-2021
12.2.1. <10 mL
12.2.2. 10 – 20 mL
12.2.3. 20 – 40 mL
12.2.4. 40 – 60 mL
12.2.5. 60 – 90 mL
12.2.6. 90 – 500 mL
12.2.7. 500 mL – 1 lit.
12.3. Market Size (US$ Mn) Forecast By Product Type, 2022-2028
12.4. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Emergency Medical Services
12.4.4. Diagnostic Laboratories
12.4.5. Academic Institutes
12.4.6. Forensic Laboratories
12.4.7. Contract Research Organizations
12.4.8. Veterinary Clinics
12.4.9. Veterinary Laboratories
12.4.10. Veterinary Hospitals
12.5. Market Size (US$ Mn) Forecast By End User, 2022-2028
12.6. Drivers and Restraints: Impact Analysis
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By End User
12.8. Key Mergers & Acquisitions
13. Middle East & Africa Prefilled Formalin Vials Market Analysis 2013–2021 and Forecast 2022–2028
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
13.2.1. GCC Countries
13.2.2. South Africa
13.2.3. Rest of Middle East and Africa
13.3. Market Size (US$ Mn) Forecast By Country, 2022-2028
13.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product Type, 2013-2021
13.4.1. <10 mL
13.4.2. 10 – 20 mL
13.4.3. 20 – 40 mL
13.4.4. 40 – 60 mL
13.4.5. 60 – 90 mL
13.4.6. 90 – 500 mL
13.4.7. 500 mL – 1 lit.
13.5. Market Size (US$ Mn) Forecast By Product Type, 2022-2028
13.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
13.6.1. Hospitals
13.6.2. Clinics
13.6.3. Emergency Medical Services
13.6.4. Diagnostic Laboratories
13.6.5. Academic Institutes
13.6.6. Forensic Laboratories
13.6.7. Contract Research Organizations
13.6.8. Veterinary Clinics
13.6.9. Veterinary Laboratories
13.6.10. Veterinary Hospitals
13.7. Market Size (US$ Mn) Forecast By End User, 2022-2028
13.8. Drivers and Restraints: Impact Analysis
13.9. Market Attractiveness Analysis
13.9.1. By Country
13.9.2. By Product Type
13.9.3. By End User
13.10. Key Mergers & Acquisitions
14. Forecast Factors: Relevance and Impact
15. Forecast Assumptions
16. Competition Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Profitability and Gross Margin Analysis By Competition
16.4. Company Deep Dive
16.4.1. Diapath S.p.A
16.4.1.1. Overview
16.4.1.2. Product and Application Portfolio
16.4.1.3. Production Footprint
16.4.1.4. Sales Footprint
16.4.1.5. Channel Footprint
16.4.1.6. Strategy
16.4.1.6.1. Marketing Strategy
16.4.1.6.2. Product Strategy
16.4.1.6.3. Channel Strategy
16.4.2. Histo- Line Laboratories Srl
16.4.2.1. Overview
16.4.2.2. Product and Application Portfolio
16.4.2.3. Production Footprint
16.4.2.4. Sales Footprint
16.4.2.5. Channel Footprint
16.4.2.6. Strategy
16.4.2.6.1. Marketing Strategy
16.4.2.6.2. Product Strategy
16.4.2.6.3. Channel Strategy
16.4.3. Cardinal Health, Inc.
16.4.3.1. Overview
16.4.3.2. Product and Application Portfolio
16.4.3.3. Production Footprint
16.4.3.4. Sales Footprint
16.4.3.5. Channel Footprint
16.4.3.6. Strategy
16.4.3.6.1. Marketing Strategy
16.4.3.6.2. Product Strategy
16.4.3.6.3. Channel Strategy
16.4.4. Leica Microsystems Sales GmbH (Leica Biosystems Nussloch GmbH)
16.4.4.1. Overview
16.4.4.2. Product and Application Portfolio
16.4.4.3. Production Footprint
16.4.4.4. Sales Footprint
16.4.4.5. Channel Footprint
16.4.4.6. Strategy
16.4.4.6.1. Marketing Strategy
16.4.4.6.2. Product Strategy
16.4.4.6.3. Channel Strategy
16.4.5. Genta Environmental Ltd.
16.4.5.1. Overview
16.4.5.2. Product and Application Portfolio
16.4.5.3. Production Footprint
16.4.5.4. Sales Footprint
16.4.5.5. Channel Footprint
16.4.5.6. Strategy
16.4.5.6.1. Marketing Strategy
16.4.5.6.2. Product Strategy
16.4.5.6.3. Channel Strategy
16.4.6. Carl Roth GmbH + Co. KG
16.4.6.1. Overview
16.4.6.2. Product and Application Portfolio
16.4.6.3. Production Footprint
16.4.6.4. Sales Footprint
16.4.6.5. Channel Footprint
16.4.6.6. Strategy
16.4.6.6.1. Marketing Strategy
16.4.6.6.2. Product Strategy
16.4.6.6.3. Channel Strategy
16.4.7. Magnacol Ltd.
16.4.7.1. Overview
16.4.7.2. Product and Application Portfolio
16.4.7.3. Production Footprint
16.4.7.4. Sales Footprint
16.4.7.5. Channel Footprint
16.4.7.6. Strategy
16.4.7.6.1. Marketing Strategy
16.4.7.6.2. Product Strategy
16.4.7.6.3. Channel Strategy
16.4.8. Serosep Limited
16.4.8.1. Overview
16.4.8.2. Product and Application Portfolio
16.4.8.3. Production Footprint
16.4.8.4. Sales Footprint
16.4.8.5. Channel Footprint
16.4.8.6. Strategy
16.4.8.6.1. Marketing Strategy
16.4.8.6.2. Product Strategy
16.4.8.6.3. Channel Strategy
16.4.9. Ultident Scientific
16.4.9.1. Overview
16.4.9.2. Product and Application Portfolio
16.4.9.3. Production Footprint
16.4.9.4. Sales Footprint
16.4.9.5. Channel Footprint
16.4.9.6. Strategy
16.4.9.6.1. Marketing Strategy
16.4.9.6.2. Product Strategy
16.4.9.6.3. Channel Strategy
16.4.10. Solmedia Limited
16.4.10.1. Overview
16.4.10.2. Product and Application Portfolio
16.4.10.3. Production Footprint
16.4.10.4. Sales Footprint
16.4.10.5. Channel Footprint
16.4.10.6. Strategy
16.4.10.6.1. Marketing Strategy
16.4.10.6.2. Product Strategy
16.4.10.6.3. Channel Strategy
17. Global Prefilled Formalin Vials Market Analysis 2013–2021 and Forecast 2022–2028 By Region
17.1. Introduction / Key Findings
17.2. Historical Market Size (US$ Mn) Analysis By Region
17.2.1. North America
17.2.2. Latin America
17.2.3. Western Europe
17.2.4. Eastern Europe
17.2.5. APEJ
17.2.6. Japan
17.2.7. Middle East & Africa
17.3. Market Size (US$ Mn) Forecast By Region
17.4. Market Attractiveness Analysis By Region
18. Global Prefilled Formalin Vials Market Analysis 2013–2021 and Forecast 2022–2028, By Product Type
18.1. Introduction/Key Finding
18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product Type, 2013-2021
18.2.1. <10 mL
18.2.2. 10 – 20 mL
18.2.3. 20 – 40 mL
18.2.4. 40 – 60 mL
18.2.5. 60 – 90 mL
18.2.6. 90 – 500 mL
18.2.7. 500 mL – 1 lit.
18.3. Market Size (US$ Mn) Forecast By Product Type, 2022-2028
18.4. Market Attractiveness Analysis By Product Type
19. Global Prefilled Formalin Vials Market Analysis 2013–2021 and Forecast 2022–2028, By End User
19.1. Introduction/Key Finding
19.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
19.2.1. Hospitals
19.2.2. Clinics
19.2.3. Emergency Medical Services
19.2.4. Diagnostic Laboratories
19.2.5. Academic Institutes
19.2.6. Forensic Laboratories
19.2.7. Contract Research Organizations
19.2.8. Veterinary Clinics
19.2.9. Veterinary Laboratories
19.2.10. Veterinary Hospitals
19.3. Market Size (US$ Mn) Forecast By End User, 2022-2028
19.4. Market Attractiveness Analysis By End User
20. Global Prefilled Formalin Vials Market Analysis 2013–2021 and Forecast 2022–2028
20.1. Market Value Share Analysis By All Segment
20.2. Y-o-Y Growth Analysis By All Segment
20.3. Absolute $ Opportunity
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Prefilled Formalin Vials Market
